Mateusz Maciejczyk

Mateusz Maciejczyk


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Pharmacological Reports
Verified
Journal Article
Closed access
Agnieszka WilczewskaAgnieszka Wilczewska
Agnieszka Wilczewska
KNKatarzyna Niemirowicz
Katarzyna Niemirowicz
KMKarolina Halina Markiewicz
Karolina Halina Markiewicz
MMMateusz Maciejczyk
Mateusz Maciejczyk

Verified
Journal Article
Open access
PDF file
Mateusz MaciejczykMateusz Maciejczyk
Mateusz Maciejczyk
EŻEwa Żebrowska
Ewa Żebrowska
ACAdrian Chabowski
Adrian Chabowski
The latest studies have indicated a strong relationship between systemic insulin resistance (IR) and higher incidence of neurodegeneration, dementia, and mild cognitive impairment. Although some of these abnormalities could be explained by chronic hyperglycaemia, hyperinsulinemia, dyslipidaemia, and/or prolonged whole-body inflammation, the key role is attributed to the neuronal redox imbalance and oxidative damage. In this mini review, we provide a schematic overview of intracellular oxidative stress and mitochondrial abnormalities in the IR brain. We highlight important correlations found so far between brain oxidative stress, ceramide generation, β-amyloid accumulation, as well as neuronal apoptosis in the IR conditions.

1 June 2016 in Pharmacological Reports
Verified
Journal Article
Closed access
KBKamil Bienias
Kamil Bienias
AFAnna Fiedorowicz
Anna Fiedorowicz
ASAnna Sadowska
Anna Sadowska
SPSławomir Prokopiuk
Sławomir Prokopiuk
MMMateusz Maciejczyk
Mateusz Maciejczyk

1 August 2018 in Archives of Oral Biology
Verified
Journal Article
Closed access
PŻPiotr Żukowski
Piotr Żukowski
Mateusz MaciejczykMateusz Maciejczyk
Mateusz Maciejczyk
DWDanuta Waszkiel
Danuta Waszkiel

25 April 2012 in Folia Histochemica et Cytobiologica
Verified
Journal Article
Open access
PDF file
DSDiana Sawicka
Diana Sawicka
MMMateusz Maciejczyk
Mateusz Maciejczyk
JMJustyna Moskwa
Justyna Moskwa
JNJacek Nikliński
Jacek Nikliński
Propolis and its compounds have been the subject of many studies due to their antimicrobial and antiinflammatory activity; however, it is now known that they also possess antitumor properties. This review aims to summarize the results of studies on the mechanism of activity of propolis and its active compounds such as CAPE and chrysin in the apoptotic process, and their influence on the proliferation of cancer cells. Our review shows that propolis and its presented compounds induce apoptosis pathways in cancer cells. The antiproliferative effects of propolis, CAPE or chrysin in cancer cells are the result of the suppression of complexes of cyclins, as well as cell cycle arrest. The results of in vitro and in vivo studies suggest that propolis, CAPE and chrysin may inhibit tumor cell progression and may be useful as potential chemotherapeutic or chemopreventive anticancer drugs. Propolis and its compounds have been the subject of many studies due to their antimicrobial and antiinflammatory activity; however, it is now known that they also possess antitumor properties. This review aims to summarize the results of studies on the mechanism of activity of propolis and its active compounds such as CAPE and chrysin in the apoptotic process, and their influence on the proliferation of cancer cells. Our review shows that propolis and its presented compounds induce apoptosis pathways in cancer cells. The antiproliferative effects of propolis, CAPE or chrysin in cancer cells are the result of the suppression of complexes of cyclins, as well as cell cycle arrest. The results of in vitro and in vivo studies suggest that propolis, CAPE and chrysin may inhibit tumor cell progression and may be useful as potential chemotherapeutic or chemopreventive anticancer drugs.

9 April 2025 in Gels
Verified
Journal Article
Open access
PDF file
NCNatalia Chylińska
Natalia Chylińska
Mateusz MaciejczykMateusz Maciejczyk
Mateusz Maciejczyk
Hyaluronic acid (HA) is a linear, unbranched polysaccharide classified as a glycosaminoglycan. While HA is found in various tissues throughout the body, over half of its total proportion is found in the skin. The role of HA in the skin is complex and multifaceted. HA maintains proper hydration, elasticity, and skin firmness, serving as a key extracellular matrix (ECM) component. With age, HA production gradually decreases, leading to reduced water-binding capacity, drier and less elastic skin, and the formation of wrinkles. Additionally, HA plays an active role in the wound-healing process at every stage. This review summarizes the current background knowledge about the role of HA in skin aging and wound healing. We discuss the latest applications of HA in aging prevention, including anti-aging formulations, nutricosmetics, microneedles, nanoparticles, HA-based fillers, and skin biostimulators. Furthermore, we explore various HA-based dressings used in wound treatment, such as hydrogels, sponges, membranes, and films.